The guidance ‘Management of Patients with Musculoskeletal and Rheumatic Conditions on Corticosteroids’ has now been superseded by the following guidance, issued on 16 June 2020. It applies to:
Management of patients with musculoskeletal and rheumatic conditions who:
- – are on corticosteroids
- – require initiation of oral/IV corticosteroids
- – require a corticosteroid injection
The new guidance can be read here [open PDF].
SOMM’s Injection Module Coordinator, Paul Hattam, has submitted his view on the guidance for corticosteroid injection that has been provided throughout the COVID-19 pandemic, as an open letter to the CSP’s ‘Frontline’ magazine.…
Read more of this article
NASS would like to bring your attention to an important new clinical survey on the impact that COVID-19 is having on axial SpA (AS) services and care.
Sport Rehabilitators and Covid-19 – working with patients and supporting the NHS
Guest blog by Nina Davies, Project Lead: Integrating Long Term Condition Training and Development, Leeds Community Healthcare NHS Trust; Co-Chair Children’s Podiatry Special Advisory Group, The College of Podiatry
A British Orthopaedic Association message to people waiting for joint replacement and other orthopaedic surgery
ARMA is happy to extend a warm welcome to the Psoriasis Association, our newest member.
The Institute of Osteopathy can confirm that osteopaths operating in all areas of the UK can now open to general practice following the implementation of the relevant adaptations required to manage the risk of infection of COVID-19.
NRAS is delighted to announce Simon Collins as the newly elected Chair of the Board of Trustees and would like to thank Gordon Taylor for four years as chair. The Society is pleased that Gordon will continue to serve as an NRAS Trustee.